🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to message these accounts privately for source information, while also receiving discount codes.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of participants share comparison images, administration instructions and claims of next-day British shipping. Sellers promote the drug there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Voice Worries

However, doctors and pharmacists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in users injecting products of uncertain source.

Some experts stated the demand for the experimental drug could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.

Service Response and Content Removal

According to the social media company, the platform has removed violative material and banned related hashtags and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also found communities with up to nine thousand members marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, filled with images of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at home.

Within minutes of joining one group, a vendor shared contact information, where the majority of transactions take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about body mass, health issues or previous experience.

Item Information and Costs

Within these groups, messages display black plastic packages with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service said it actively moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her team has previously seen individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to possibly significant health risks”.